Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 344

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Open access
Heine, Annkristin, Held, Stefanie Andrea Erika, Daecke, Solveig Nora, Wallner, Stephanie, Yajnanarayana, Sowmya Parampalli, Kurts, Christian, Wolf, Dominik, Brossart, Peter·2013·Blood
DOI 10.1182/blood-2013-03-484642
Open this paper in CoChat — free account

Abstract

Key Points: The JAK-inhibitor ruxolitinib affects dendritic cell differentiation, phenotype, and function leading to impaired T-cell activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2013-03-484642

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 344

Metadata

Authors
Heine, A., Held, S. A. E., Daecke, S. N., Wallner, S., Yajnanarayana, S. P., Kurts, C., Wolf, D., & Brossart, P.
Venue
Blood
Publisher
American Society of Hematology
Published
2013-08-15
Volume
122
Issue
7
Pages
1192-1202
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
DOI
10.1182/blood-2013-03-484642
OpenAlex
W2078678444
Cited by
344
References
33
FWCI
13.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. https://app.cochat.ai/papers/10.1182/blood-2013-03-484642
The paper
Heine, A., Held, S. A. E., Daecke, S. N., Wallner, S., Yajnanarayana, S. P., Kurts, C., Wolf, D., & Brossart, P. (2013). The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood. https://doi.org/10.1182/blood-2013-03-484642

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.